Annual Cornea Day
(Organised by ESCRS and EuCornea)

Friday 26 February | 09.30 - 16.30
Trianti Room

Chairpersons: J. Güell SPAIN (EUCORNEA) | R. Nuijts THE NETHERLANDS (ESCRS)

09.30 – 11.00
Section 1: Ocular Surface Disease: What Worked and What Did Not (EUCORNEA)

Moderators: M. Labetoulle FRANCE, F. Malecaze FRANCE

Keynote Speaker:

• 09.30
• M. Labetoulle FRANCEEfficacy and pitfalls of diagnostic methods of viral diseases of the ocular surface
  

Case Presentations

• 09.50
• A. McElvanney UKSudden onset of uniocular cicatrisation associated with a skin rash
  
• 09.56
• E. Mrukwa-Kominek POLANDNew generation eye drops with cyclosporin A in the treatment of severe dry eye syndrome: case report
  
• 10.02
• P. Antonopoulou UK Dramatic resolution of acne rosacea and secondary ocular surface disease after a 14 day course of azithromycin 1.5% eye drops
  
• 10.08
• D. Pavlenko UKRAINEPatient compliance as an effectiveness factor of complicated dendritic herpetic keratitis treatment
• 10.14 
• J. Ashar INDIAComparison of ROSE K XL, miniscleral (MS) and scleral (S) contact lens (CL) for ocular surface disorders
• 10.20
• C. Kalamkar INDIAProfile, treatment and outcomes of ocular surface squamous neoplasia (OSSN) in a rural population of central India
• 10.26
• Q. Palomino SPAINClinical management of ulcer perforation due to facial paralysis
• 10.32
• V. Achtsidis GREECEOcular surface disease secondary to corneal hypoesthesia and denervation in subjects with diabetic neuropathy
• 10.38
• J. Asher INDIAPaired eye comparison of cyclosporine (CSA) 0.05% and chloroquine (CHQ) eye drops for moderate dry eyes
• 10.44
• A.J Kanellopoulos GREECERefractive power changes in ectasia management with the Athens Protocol (AP): topo-guided PTK and CXL
• 10.50
• Discussion
• 11.00
• End of session

11.00 – 12.30
Section 2: Management of Corneal Complications after Refractive Surgery (ESCRS)

Moderators: R. Bellucci ITALY, G. Grabner AUSTRIA

Keynote Speaker:

• 11.00
• G. Kymionis GREECECombined refractive surgery and corneal cross-linking (CXL plus) for corneal ectasia
  

 Case Presentations

• 11.20
• S. Jonker THE NETHERLANDSTreatment strategies for epithelial down-growth after Artisan implantation
  
• 11.27
• A. Bansal INDIAPost SMILE interface fluid collection: a case of ‘shifting ectasia'
  
• 11.34
• A. Lazaridis GERMANY Refractive lenticule transplantation (RLT) and ICL implantation for correction of iatrogenically-induced hyperopic astigmatism after LASIK
  
• 11.41
• A. Mani UKCase reports of intraoperative complication of free flap (cap) with IntraLase femtosecond-assisted laser flap creation in laser in situ keratomileusis (LASIK) and suggested management of this condition for good visual outcome
• 11.48
• I. Mallias GREECEPhototherapeutic keratectomy for the treatment of severe anterior stromal haziness after epidemic keratoconjunctivitis
• 11.55
• K. Osman SUDANVisual and refractive outcome of MyoRing implantation in Sudanese keratoconus patients
• 12.02
• J. Bourges FRANCEPhotorefractive keratectomy (PRK) depth of ablation after cross-linking
• 12.09
• A. Hervás Ontiveros SPAIN The use of iontophoresis in corneal collagen cross-linking technique
• 12.16
• Discussion
• 12.30
• End of session

13.30 – 15.00
Section 3: Tip and Pitfalls in Corneal Graft Surgery: DALK, DESK, PK (EuCornea)

Moderators: M. Balidis GREECE, G. Kymionis GREECE

Keynote Speaker:

• 13.30
• D. Mikropoulos GREECEPenetrating keratoplasty: the end of an era
  

 Case Presentations

• 13.50
• C. Pedrosa  PORTUGALCataract and corneal lamellar surgery in aniridia
  
• 13.56
• R. Bellucci ITALYSurgical treatment of Urrets-Zavalia syndrome
  
• 14.02
• G. Chatzilaou GREECE Use of a novel model foldable artificial cornea for treatment of blindness due to severe ocular surface disease
  
• 14.08
• D. Miltsakakis GREECEConjunctival limbal autograft and PKP autograft in a patient with unilateral alkali burn: case report
• 14.14
• K. Samaras GREECE Accelerated resolution of painful corneal hydrops with injection of air in the AC as part of the preoperative regime for keratoplasty in patients with advanced keratoconus
• 14.20
• A. Villarrubia SPAINDALK small bubble technique assisted with femtosecond laser
• 14.26
• P. Nelli INDIA Favourable visual outcome and intraocular pressure control in a case of post penetrating keratoplasty glaucoma
• 14.32
• K. Droutsas GREECE FA simple wetlab model for Descemet's membrane endothelial keratoplasty (DMEK)
• 14.38
• M. Ismail EGYPT Solid state cornea
• 14.44
• J. Sandoval Codoni SPAINSMycophenolate mofetil in the management of refractory corneal graft rejection in high-risk keratoplasty
• 14.50
• Discussion
• 15.00
• End of session

15.00 – 16.30
Section 4: Miscellaneous (ESCRS)

Moderators: R. Nuijts THE NETHERLANDS, J. Vryghem BELGIUM

Keynote Speaker:

• 15.00 
• M.J. Tassignon BELGIUMWhere are we with cornea regeneration?
  

 Case Presentations

• 15.20
• I. Gama PORTUGALSerratia marcescens keratitis and something more: a complicated clinical case
  
• 15.25
• H. Madi UKAn unusual case of corneal graft failure
  
• 15.30
• M. Tsatsos UK Corneal response to canakinumab in cryopyrin - associated periodic fever syndrome
  
• 15.35
• T. Young-Zvandasara UKDevelopment of scleromalacia with ectasia in acanthamoeba keratitis
• 15.40      
• R. Altan-Yaycioglu TURKEYBilateral disciform keratitis following adenoviral keratoconjunctivitis
• 15.45
• T. Balaji Prasad UKSubconjunctival bevacizumab (Avastin) combined with corneal argon laser photocoagulation (SCALP) treatment for corneal neovascularisation
• 15.50
• A. Celebi TURKEYThe role of anterior segment optical coherence tomography in the management of intracorneal foreign body: case report
• 15.55
• S. Elnayef SPAINRecurring ulcer in 9 year old girl treated with amniotic membrane transplantation: anterior segment OCT evaluation
• 16.00
• K. Samaras GREECEOcular surface tumours: differential diagnosis and treatment
• 16.05
• J. Sandoval Codoni SPAINArchipelago keratitis associated to herpes zoster ophthalmicus: case report
• 16.10
• S. Srinivasan UKCataract surgery following endogenous endophthalmitis
• 16.15
• Discussion
• 16.30
• End of session